Institutional Ethics committee approval will be obtained and trial registered with Clinical Trial Registry of India.

Patients informed consent will be taken and the procedure explained to them in their own language.

 Study design: Prospective, randomized, comparative, hospital-based, single center interventional clinical study in patients with planned phacoemulsifiction surgery.

 Study Setting: Nethradhama Superspeciality Eye Hospital, Bangalore.

 Patient selection criteria:

 Patients will be enrolled into the clinical study and randomized in a ratio of 1:1 by simple random sampling through computer generated lottery method.

The patients will also be willing to attend routine follow-up care as described below (1 day up to 6 months post-surgery).

 Study Duration: Time frame for patient visits and examination are pre-operative, day of surgery, postoperative days 1, 15, month 1, 3 and 6

Method of data collection:

 Data will be collected on the demographic profile (age, gender, address, and occupation) and ocular parameters of the patients, as measured by slit lamp examination, 90D lens with slit lamp, and indirect ophthalmoscopy.

Before the surgery, all patients will undergo a complete ophthalmic examination including subjective refraction, slit lamp biomicroscopy, noncontact tonometry (Topcon CT-80), dilated fundus examination, OCT macula. (Optovue RTVue 100, USA)

 The study participants will be divided into two groups –

Study Group: Sub-Tenon’s triamcinolone acetonide (12 mg/ml) and 0.1ml intracameral moxifloxacin (0.5%) (Auromox, Aurolab, India) administered at the end of surgery.

Control Group: Standard post-operative topical antibiotic-steroid regimen

 Intervention and Procedure:

Phacoemulsification Surgery: All patients will undergo either standard phacoemulsification cataract surgery or Femstosecond assisted laser assisted phacoemulsification by a single surgeon. All procedures will be conducted under topical anesthesia.

Postoperative Intervention: